Houlihan Lokey (HLI) Gets a Hold from UBS
In a report released yesterday, from UBS initiated coverage with a Hold rating on Houlihan Lokey and a price target of $193.00. The company’s shares closed yesterday at $180.42.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Houlihan Lokey has an analyst consensus of Moderate Buy, with a price target consensus of $216.80.
Based on Houlihan Lokey’s latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of $659.45 million and a net profit of $111.78 million. In comparison, last year the company earned a revenue of $574.96 million and had a net profit of $93.55 million
Based on the recent corporate insider activity of 30 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of HLI in relation to earlier this year. Most recently, in September 2025, IRWIN GOLD, the CO-CHAIRMAN of HLI sold 6,811.00 shares for a total of $1,380,930.25.
Read More on HLI:
